Diphtheria Toxin as a Molecular Tool in the Study of Acidic Fibroblast Growth Factor Signalling

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 5-6, 1997, Pages 391-409

  Wiȩdłocha, Antoni ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acidic fibroblast growth factor signalling; Diphtheria toxin; Membrane translocation; Nuclear targeting; Protein toxins

Indexed keywords

DIPHTHERIA TOXIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR;

ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CELL LINE; HUMAN; METABOLISM; MOLECULAR PROBE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DIPHTHERIA TOXIN; FIBROBLAST GROWTH FACTOR 1; HUMANS; MOLECULAR PROBES; ORGAN SPECIFICITY; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 0031298679     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (178)

1. ACLAND P., DIXON M., PETERS G. and DICKSON C. (1990): Subcellular fate of the Int-2 oncoprotein is determined by choice of initiation codon. Nature, 343, 662-665.
2. ARKOWITZ R. A. and BASSILANA M. (1994): Protein translocation in Escherichia coli. Biochim. Biophys. Acta, 1197, 311-343.
3. ARORA N. and LEPPLA S. H. (1993): Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J. Biol. Chem., 268, 3334-3341.
4. ARORA N. and LEPPLA S. H. (1994): Fusion of anthrax toxin lethal factor with Shiga toxin and diphtheria toxin enzymatic domains are toxic to mammalian cells. Infect. Immun., 62, 4955-4961.
5. AULLO P., GIRY M., OLSNES S., POPOFF M. R., KOCKS C. and BOQUET P. (1993): A chimeric toxin to study the role of the 21 kDa GTP binding protein rho in the control of actin microfilament assembly. EMBO J., 12, 921-931.
6. BALDIN V., ROMAN A. M., BOSC-BIERNE I., AMALRIC F. and BOUCHE G. (1990): Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J., 9, 1511-1517.
7. BASILICO C. and MOSCATELLI D. (1992): The FGF family of growth factors and oncogenes. Adv. Cancer Res., 59, 115-165.
8. BELLOT F., CRUMLEY G., KAPLOW J., SCHLESINGER J., JAYE M. and DIONE C. A. (1991): Ligand-induced transphosphorylation between different FGF reseptors. EMBO J., 10, 2849-2854.
9. BLOCH-GALLEO E., LEROUX I., JOLIOT A. H., VOLOVITCH M., HEDERSON C. E. and PROCHIANTZ A. (1993): Antennapedia homebox peptide enhances growth and branching of embryonic chicken motoneurons in vitro. J. Cell Biol., 120, 485-492.
10. BONIFACI N., SITIA R. and RUBATELLI A. (1995): Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS, 9, 995-1000.
11. BORK P. and MARGOLIS B. (1995): A new phosphotyrosine interaction domain. Cell, 80, 693-694.
12. BOUCHE G., GAS N., PRATS H., BALDIN V., TAUBER J. P., TEISSIE J. and AMALRIC F. (1987): Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition. Proc. Natl. Acad. Sci. USA, 84, 6770-6774.
13. BOYD J., OZA M. N. and MURPHY J. R. (1990): Molecular cloning and DNA sequence analysis of diphtheria toxin iron-dependet regulatory element (dtxR) from Corynebacterium diphtheriae. Proc. Natl. Acad. Sci. USA, 87, 5968-5972.
14. BOYER B. and THIERY J. P. (1993): Cyclic AMP distinguishes between two functions of acidic FGF in a rat blader carcinoma cell line. J. Cell Biol., 120, 767-776.
15. BUCHNER K. (1995): Protein kinase C in the transduction of signals toward and within the cell nucleus. Eur. J. Biochem., 228, 211-221.
16. BUGLER B., AMALRIC F. and PRATS H. (1991): Alternative initiation of translation determines cytoplasmic or nuclear localization orf basic fibroblast growth factor. Mol. Cell. Biol., 1, 573-577.
17. BURGESS W. H. and MACIAG T. (1989): The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem., 58, 576-606.
18. BURGESS W. H. (1991): Structure-function studies of acidic fibroblast growth factor. Ann. NY Acad. Sci., 638, 89-97.
19. BURGESS W. H., SHAHEEN A. M., RAVERA M., JAYE M., DONOHUE P. J. and WINKLES J. A. (1990): Possible dissociation of the heparin-binding and mitogenic activities of heparin binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. J. Cell Biol., 111, 2129-2138.
20. BURGESS W. H., SHAHEEN A. M., HAMPTON B., DONOHUE P. J. and WINKLES J. A. (1991): Structure-function studies of heparin-binding (acidic fibroblast) growth factor using site-directed mutagenesis. J. Cell. Biochem., 45, 131-138.
21. BURRUS L. W., ZUBER M. E., LUEDDECKE B. A. and OLWIN B. B. (1992): Identyfication of a cystein-rich receptor for fibroblast growth factors. Mol. Cell. Biol., 12, 5600-5609.
22. CANTLEY L. C., AUGER K. R., CARPENTER C., DUCKWORTH B., GRAZIANI A., KAPELLER R. and SOLTOFF S. (1991): Oncogenes and signal transduction. Cell, 64, 281-302.
23. CAO Y., EKSTROM M. and PETTERSSON R. F. (1993): Characterization of the nuclear translocation of acidic fibroblast growth factor. J. Cell Sci., 104, 77-87.
24. CHAVAN A. J. and HALEY B. E. (1994): Interactions of nucleotides with acidic fibroblast growth factor (FGF-1). Biochemistry, 33, 7193-7202.
25. CHELLAIAH A. T., MCEWEN D. G., WERNER S., XU J. and ORNIC D. M. (1994): Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1. J. Biol. Chem., 269, 11620-11627.
26. CHOE S., BENNETT M. J., FUJII G., CURMI P. M., KATARDJIEFF K. A., COLLIER R. J. and EISENBERG D. (1992): The crystal structure of diphtheria toxin. Nature, 357, 216-222.
27. CLARKE P. R. (1994): Switching of MAP kinases. Curr. Biol., 4, 647-650.
28. CLARKE S. (1992): Protein isoprenylation and methylation at carboxy-terminal cysteine residues. Annu. Rev. Biochem., 61, 355-386.
29. COHEN G. B., REN R. and BALTIMORE D. (1995): Modular binding domains in signal transduction proteins. Cell, 80, 237-248.
30. COLLIER R. J. and KANDEL J. (1971): Structure and activity of diphtheria toxin. I. Thiol-dependent dissociation of fraction of toxin into enzymically active and inactive fragments. J. Biol. Chem., 246, 1496-1503.
31. COPELAND R. A., JI H., HALFPENNY A. J., WILLIAMS R. W., THOMPSON K. C., HERBER W. K., THOMAS K. A., BRUNER M. W., RYAN J. A., SANYL G., SIRIT R. D., YAMAZAKI S. and MIDDAUGH C. R. (1991): The structure of human acidic fibroblasts growth factor and its interaction with heparin. Arch. Biochem. Biophys., 289, 53-61.
32. CURTIS B. M., WIDMER M. B., DEROOS P. and QWANSTROM E. E. (1990): IL-1 and its receptor are translocated to the nucleus. J. Immunol., 144, 1295-1303.
33. DE BEUS E., BROCKENBROUGH J. S., HONG B. and ARIS J. P. (1994): Yeast NOP2 encodes an essential nucleolar protein with homology to a human proliferation marker. J. Cell. Biol., 127, 1799-1813.
34. DE CATMILLI P., EMR S. D., MCPHERSON P. S. and NOVIK P. (1996): Phosphoinositides as regulators in membrane traffic. Science, 271, 1533-1539.
35. DEROSSI D., CALVET S., TREMBLEAN A., BRUNISSEN A., CHASSAING G. and PROCHIATZ A. (1996): Cell internalization of the third helix of the Antennapedia horneodomain is receptor-independent. J. Biol. Chem., 271, 18188-18193.
36. DONNELLY J. J., ULMER J. B., HAWE L. A., FREEDMAN A., SHI X. P., LEANDER K. P., SHIWER J. W., OLIFF A. I., MARTINEZ D. and MONTGOMERY D. (1993): Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudemonas exotoxin. Proc. Natl. Acad. Sci. USA, 90, 3530-3534.
37. DRAPER R. K. and SIMON M. I. (1980): The entry of diphtheria toxin into the mammalian cell cytoplasm: evidence for lysosomal involvment. J. Cell Biol., 87, 849-854.
38. DRAZIN R., KANDEL J. and COLLIER R. J. (1971): Structure an activity of diphtheria toxin. II. Atack by trypsin at a specific site within the toxin molecule. J. Biol. Chem., 246, 1504-1510.
39. ENDICOTT J. A. and LING V. (1989): The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem., 58, 137-171.
40. FALNES P. Ø., CHOE S., MADSHUS I. H., WILSON B. A. and OLSNES S. (1994): Inhibition of membrane translocation of diphtheria toxin A-fragment by internal disulfide briges. J. Biol. Chem., 269, 8402-8407.
41. FALNES P. Ø. and OLSNES S. (1995). Cell-mediated reduction and incomplete membrane translocation of diphtheria toxin mutants with internal disulfides in the A-fragment. J. Biol. Chem., 270, 20787-20793.
42. FÅLNES P. Ø., WIEDLOCHA A., RAPAK A. and OLSNES S. (1995): Farnesylation of CaaX-tagged diphtheria toxin A-fragment as a measure of transfer to the cytosol. Biochemistry, 34, 11152-11159.
43. FANTL W. J., JOHNSON D. E. and WILLIAMS L. T. (1993): Signaling by receptor tyrosine kinases. Annu. Rev. Biochem., 62, 453-481.
44. FITGERA D. (1996): Why toxins. Semin. Cancer. Biol., 7, 87-95.
45. FOLKMAN J. Y. and SHING Y. (1992): Angiogenesis. J. Biol. Chem., 267, 10931-10934.
46. FONAGY A., SWIDERSKI C., WILSON A., BOLTON W., KENYON N., and FREEMAN J. W. (1993:) Cell cycle regulated expression of nucleolar antigen P120 in normal and transformed human fibroblasts. J. Cell. Physiol., 154, 16-27.
47. FRANKEL A. D. and PABO C. O. (1988): Cellular uptake of the Tat protein from human immunodeficiency virus. Cell, 55, 1189-1193.
48. FRIEDMAN S., ZHAN X. and MACIAG T. (1994): Mutagenesis of the location sequence in FGF-1 alters protein stability but not mitogenic activity. Biochem. Biophys. Res. Commun., 198, 1203-1208.
49. FRIESEL R. E. and MACIAG T. (1995): Molecular mechanism of angiogenesis: fibroblast growth factor signal transduction. FASEB J., 9, 919-925.
50. GIVOL D. and YAYON A. (1992): Complexity of FGF receptors: genetic basis for structural diversity and fuctional specificity. FASEB J., 6, 3362-3369.
51. GLOMSET J. A., GELB M. H. and FARNSWORTH C. C. (1990): Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem. Sci., 15, 139-142.
52. GREENFIELD L., BJORN M. J., HORN G., FONG D., BUCK G. A., COLLIER R. J. and KAPLAN D. A. (1983): Nucleotide sequence of the structural gene for diphtheria toxin caried by coynebacteriophage beta. Proc. Natl. Acad. Sci. USA, 80, 6853-6857.
53. GRENFELL A., SMITHERS N., MILLER K. and SOLARI R. (1989): Receptor mediated endocytosis and nuclear transport of human interleukin. Biochem. J., 264, 813-822.
54. HANNEKEN A., YING W., LENG N. and BAIRD A. (1994): Identification of soluble forms of the fibroblast growth factor receptor in blood. Proc. Natl. Acad. Sci. USA, 91, 9170-9174.
55. HARPER J. W. and LOBB R. R. (1988): Reductive methylation of lysine residues in acidic fibroblast growth factor: effect on mitogenic activity and heparin affinity. Biochemistry, 27, 671-678.
56. HE J. and FURMANSKI P. (1995): Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature, 373, 721-724.
57. HELDIN C. H. (1995): Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223.
58. HOU J., KAN M., MCKEEHAN K., MCBRIDGE G., ADAMS P. and MCKEEHAN W. L. (1991): Fibroblast growth factor receptors from liver vary in three structural domains. Science, 251, 665-668.
59. HUANG J., MOHAMMADI M., RODRIGUES G. A. and SCHLESSINGER J. (1995): Reduced activation of RAF-1 and MAP kinases by a fibroblast growth factor receptor mutant deficient in stimulation of phosphatidylinositil hydrolisis. J. Biol. Chem., 270, 5065-5072.
60. IMAMURA T., ENGLEKA K., ZHAN X., TOKITA Y., FOROUGH R., ROEDER D., JACKSON A., MAIER J. A. M., HLA T. and MACIAG T. (1990): Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science, 249, 1567-1570.
61. IMAMURA T., OKA S., TAKANASHI T. and OKITA Y. (1994): Cell cycle-dependent nuclear localization of exogenously added fibroblast growth factor-1 in BALB/c 3T3 and human vascular endothelial cells. Exp. Cell Res., 215, 363-372.
62. IMAMURA T., TOKITA Y. and MITSUI Y. J. (1992): Identification of a heparin-binding growth factor-1 nuclear translocation sequence by deletion mutation analysis. J. Biol. Chem., 267, 5676-5679.
63. JACKSON A., TARANTINI F., GAMBLE S., FIEDMAN S. and MACIAG T. (1995): Release of fibroblast growth factor-1 from NH3T3 cells in response to temperature involves the function of cysteine residues. J. Biol. Chem., 270, 33-36.
64. JAYE M., LYALL R. M., MUDD R., SCHLESSINGER J. and SARWER N. (1988): Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells. EMBO J., 7, 963-969.
65. JAYE M., HOWK R., BURGES W., RICCA G. A., CHIU M. I., RAVERA M. W., O'BRAIEN W. S., MODI S. W., MACIAG T. and DROHAN W. N. (1986): Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization, Science, 233, 541-545.
66. JOHNSON D. E., LEE P. L., LU J. and WILLIAMS L. T. (1990): Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol. Cell Biol., 10, 4728-4736.
67. JOHNSON D. E., LU J., CHEN H., WERNER S. and WILLIAMS L. T. (1991): The human fibroblast growth factor receptor genes: a common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol. Cell Biol., 11, 4627-4634.
68. JOHNSON D. E. and WILLIAMS L. T. (1993): Structural and functional diversity in the FGF receptor multigene family of growth factors and oncogenes. Adv. Cancer Res., 60, 1-41.
69. JOHNSTON C. L., COX H. C., GOMM J. J. and COOMBES R. C. (1995): Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. J. Biol. Chem., 270, 30643-30650.
70. JONAS L., WALZEL H., BREMER H. and WIEDLOCHA A. (1992): Comparative studies on internalization of gold labelled mistletoe lectin I (MLI), its subunits, and of an immunotoxin into mouse L1210V leukemic cells. Acta Histochem., 92, 46-53.
71. JOUANNEAU J., GAVRILOVIC J., CRUELLE D., JAYE M., MOENS G., CARUELLE J. P. and THIERY J. P. (1991): Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. Proc. Natl. Acad. Sci. USA, 88, 2893-2897.
72. JUNGNICKEL B., RAPOPORT T. A. and HARTMAN E. (1994): Protein translocation: common themes from bacteria to man. FEBS Lett., 346, 3-16.
73. KAN M., WANG F., XU J., CRABB J. W., HOU J. and MCKEEHAN W. L. (1993): An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science, 259, 1918-1921.
74. KAVANAUGH W. M., TURCK C. W. and WILLIAMS L. T. (1995): PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science, 268, 1177-1179.
75. KAVANAUGH W. M. and WILLIAMS L. T. (1994): An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science, 266, 1861-1865.
76. KIEFER P., ACLAND P., PAPPIN D., PETERS G. and DICKINSON C. (1994): Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3. EMBO J., 13, 4126-4136.
77. KIEFER P. and DICKINSON C. (1995): Nucleolar association of fibroblast growth factor 3 via specific sequence motive has inhibitory effect on cells growth. Mol. Cell Biol., 15, 4364-4374.
78. KILKENNY M. D. and HILL D. J. (1996): Perinuclear localization of an intracellular binding protein related to the fibroblast growth factor (FGF) receptor 1 is temporary associated with the nuclear trafficking of FGF-2 in proliferating epiphyseal growth plate chondrocytes. Endocrynology, 137, 5078-5089.
79. KIMURA H. (1994): Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity. Proc. Natl. Acad. Sci. USA, 90, 2165-2169.
80. KLAGSBURN M. and D'AMORE P. A. (1991): Regulators of angiogenesis. Annu. Rev. Physiol., 53, 217-239.
81. KLINGENBURG O. and OLSNES S. (1996): Ability of methothrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphtheria toxin. Biochem. J., 313, 647-653.
82. KLINGENBERG O., WIEDLOCHA A., RAPAK A., MUNOZ R., FALNES P. Ø. and OLSNES S. (1997): Evidence that the lack of mitogenic activity of the aFGF mutant K132E is due to a defect in its mtracellular action (submitted).
83. KOCH C. A., ANDERSON D., MOREN M. F., ELLIS C. and PAWSON T. (1991): SH2 and SH3 domains: elements that control interaction of cytoplasmic signaling proteins. Science, 252, 668-674.
84. LEPPLA S., DORLAND R. B. and MIDDLEBROOK J. L. (1980): Inhibition of diphtheria toxin degradation and cytosolic action by chloroquine. J. Biol. Chem., 255, 2247-2250.
85. Li W., PARK W., NUIJENS A., SLIWKOWSKI M. X. and KELLER G. A. (1996): Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene, 12, 2473-2477.
86. LONDON E. (1992): Diphtheria toxin: membrane interaction and membrane translocation. Biochim. Biophys. Acta, 1113, 25-51.
87. LUTZ R., TRUJILLO M. A., DENHAM K., WENGER L. and SINENSKY M. (1992): Nucleoplasmic localization of prelamin A: implication for prenylation-dependent lamin A assembly into nuclear lamina. Proc. Natl. Acad. Sci. USA, 89, 3000-3004.
88. MACIAG T., ZHAN X., GAFRINKEL S., FRIEDMAN S., PRUDOWSKI I., JACKSON A., WESSENDORF J., HU X., GAMBLE S., BROWN S., TARANTINI F. and ZIMRIN A. (1994): Novel mechanism of fibroblast growth factor 1 function. Rec. Prog. Hormone Res., 49, 105-123.
89. MADSHUS I. H., WIEDLOCHA A. and SANDVIG K. (1994): Intermediates in translocation of diphtheria toxin across the plasma membrane. J. Biol. Chem., 269, 4648-4652.
90. MAKER P. A. (1995): Identification and characterization of a novel, intracellular isoform of fibroblast growth factor receptor-1 (FGFR-1). J. Cell. Physiol., 169, 380-390.
91. MAHER P. A. (1996): Nuclear translocation of fibroblast growth factor (FGF) receptors in response to FGF-2. J. Cell Biol., 134, 529-536.
92. MALI M., ELENIUS K., MIETTINEN H. M. and JALKANEN M. (1993): Inhibition of basic fibroblast growth factor-induced growth promotion by overexpression of syndecan 1. J. Cell Biol., 268, 24215-24222.
93. MARNELL M. H., STOOKEY M. and DRAPER R. K. (1982): Monensin bloks the transport of diphtheria toxin to the cell cytoplasm. J. Cell Biol., 93, 57-62.
94. MARSHALL C. J. (1995): Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80, 179-185.
95. MASCARELLI F., FUHRMANN G. and COURTOIS Y. (1993): aFGF binding to low and high affinity receptors induces both aFGF and aFGF receptor dimerization. Growth Factors, 8, 211-233.
96. MASON I. J. (1994): The ins and outs of fibroblast growth factors. Cell, 78, 547-552.
97. MCGRATH J. P. and VARSHAVSKY A. (1989): The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature, 340, 400-404.
98. MCLESKE S. W., DING I. Y. F., LIPMAN M. E. and KERN F. G. (1994): MDA-MB-134 brest carsinoma cells overexpress fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res., 54, 523-530.
99. MILNE J. C, BLANCE S. R., HANNA P. C. and COLLIER R. J. (1995): Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologus protein fused to its amino- or carboxy-terminus. Mol. Microbiol., 15, 661-666.
100. MONZAT V., RATOVO G., ESTIVAL A., FANJUL M., BERTRANT C., CLEMENT B., VAYSSE N., HOLLANDE E. and CLEMENTE F. (1996): Expression of two FGF-2 isoforms in pancreatic acinar cells (AR4-2J). Intracellular localization and role in the regulation of the extracellular matrix biosynthesis. Eur. J. Cell Biol., 69, 316-326.
101. MOROTANU J. and RIORDAN J. F. (1994): Nuclear translocation of angiogenic proteins in endothelial cells: an essential step in angiogenesis. Biochemistry, 33, 12535-12539.
102. MOROIANU J. and RIORDAN J. F. (1994): Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc. Natl. Acad. Sci. USA, 90, 1677-1681.
103. MOSKAUG J. Ø., SANDVIG K. and OLSNES S. (1988): Low pH-induced release of diphtheria toxin A-fragment in Vero cells. Biochemical evidence for transfer to the cytosol. J. Biol. Chem., 263, 2518-2525.
104. MOSS J. and VAUGHAM M. (1990): ADP-ribosylating toxins and G proteins. Insights into signal transduction. Am. Soc. Microbiol., Washington.
105. MURPHY J. R. (1985): The diphtheria toxin structural gene. Curr. Top. Microbiol. Immunol., 118, 235-251.
106. NABE E. G., YANG Z. Y., PLAUTZ G., FOROUGH R., ZAHN X., HAUDENSCHILD C. C., MACIAG T. and NABEL G. J. (1993): Recombinant fibroblast growth factor-1 promotes intymal hyperplasia and angiogenesis in arteria in vivo. Nature, 362, 844-846.
107. NAGLICH J. G., METHERALL J. E., RUSSELL D. W. and EIDELS L. (1992): Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell, 69, 1051-1061.
108. NEUFELD G., MITCHELL R., PONTE P. and GOSPODAROWICZ D. (1988): Expression of human fibroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomus cell growth. J. Cell Biol., 106, 1385-1394.
109. NURCOMBE V., FORD M. D., WILDSCHUD J. A. and BARTLET P. F. (1993): Developmental regulation of neuronal response to FGF-1 and FGF-2 by heparan sulfate proteglycan. Science, 260, 103-106.
110. OLSNES S., KLINGENBERG O., FÅLNES P. Ø, LANZREIN M. and WIEDLOCHA A. (1996): Translocation of diphtheria toxin across cellular membranes. In: FRANDSEN P. L. and ALOUF J. E.: Bacteria protein toxins. Publ. G. Fisher Verlag, Stuttgart, New York, 154-160.
111. OLSNES S., REFSNES K. and PIHL A. (1974): Mechanism of action of the toxic lectins abrin and ricin. Nature, 249, 627-631.
112. OLSNES S., MOSKAUGH J. Ø., STENMARK H. and SANDVIK K. (1988): Diphtheria toxin entry: protein translocation in the reverse direction. Trends Biochem., 13, 348-351.
113. OLSNES S., STENMARK H., MOSKAUG J. Ø., MCGILL S., MADSHUS I. H. and SANDVIG K. (1990): Protein toxins with intracellular targets. Microbiol. Pathogenesis, 8, 163-168.
114. OLSNES S., VAN DEURS B. and SANDVIG K. (1993): Protein toxins acting on intracellular targets: cellular uptake and translocation to the cytisol. Med. Microbiol. Immunol., 182, 65-81.
115. OLWIN B. B. and RAPRAEGER A. (1992): Repression of myogenic differentiation by aFGF, bFGF and K-FGF is department on cellular heparan sulfate. J. Cell. Biol., 118, 631-639.
116. ORR-URTREGER A., BEDFORD M. T., BURAKOWA T., ARMAN E., ZIMMER Y., YAYON A., GIVOL D. and LONAI P. (1993): Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol., 158, 475-486.
117. PAPINI E., SANDOMA D., RAPUOLI R. and MONTECUCCO C. (1988): On the membrane translocation of diphtheria toxin: a low pH the toxin induces ion channels on cells. EMBO J., 7, 3353-3359.
118. PAPPENHEIMER A. M. JR. (1977): Diphtheria toxin. Annu. Rev. Biochem., 46, 69-94.
119. PAPROCKA M., WIEDLOCHA A. and RADZIKOWSKI C. (1990): Mouse L1210 V leukemia as a model to analyse efficiency of leukemic cells elimination by immunotoxin, antibody and complement and cytostatics. In vivo, 4, 204-214.
120. PAWSON T. (1995): Protein modules and signaling networks. Nature, 373, 573-580.
121. PAWSON T. and SCHLESSINGER J. (1993): SH2 and SH3 domains. Curr. Biol., 3, 434-442.
122. POWELL P. P. and KLAGSBRUN M. (1991): Three forms of rat basic fibroblast growth factor are made from a single mRNA and localize to the nucleus. J. Cell Physiol., 148, 202-210.
123. PRIOR T. I., FITZGERALD D. J. and PASTAN I. (1991): Barnase toxin: a new chimeric toxin composed of Pseudomonas exotoxin A and barnase. Cell, 64, 1017-1023.
124. PROCHIATZ A. (1966): Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr. Opin. Neurobiol., 6, 629-634.
125. PRUDOWSKI I., SAVION N., ZHAN X., FRIESEL R., XU J., MCKEEHAN W. L. and MACIAG T. (1994): Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1. J. Biol. Chem., 269, 31720-31724.
126. PRYDZ K., HANSEN S. H., SANDVIG K. and VAN DEURS B. (1992): Effects of brefeldin A on endocytosis, transcytosis and transport to the Golgi complex in polarized MDCK cells. J. Cell Biol., 119, 259-272.
127. RADZIKOWSKI C. and WIEDLOCHA A. (1988): Monoclonal antibodies, their application in oncology. In OSTROWSKI W. (ed.): Progress in biotechnology. Ossolineum, Wrocław, Warszawa, 145-176 (in polish).
128. RENAUD F., DESSET S., OLIVER L., GIMENEZ-GALLEGO G., VAN OBBERGHEN E., COURTOIS Y. and LAURENT M. (1996): The neurotrophic activity of fibroblast growth factor-1 (FGF1) depends on endogenous FGF1 expression and is independent of the mitogen-activated protein kinase cascade pathway. J. Biol. Chem., 271, 2801-2811.
129. ROELSE J., GROMME M., MOMBURG F., HAMMERLING G. and NEEFJEES J. (1994): Trimming of TAP-translocated peptides in the endiplasmatic reticulum and in the cytosol during recycling. J. Exp. Med., 180, 1591-1597.
130. RUBATELLI A. and SITA R. (1995): Entry of exogenous polypeptides into the nucleus of living cells: facts and speculation. Trends Cell Biol., 5, 409-412.
131. RUOSLAHTI E. and YAMAGUCHI Y. (1991): Proteoglycans as modulators of growth factor activities. Cell, 64, 867-869.
132. RYAN K. R. and JENSEN R. E. (1995): Protein translocation across mitochondrail membrane: what a long, strange trip it is. Cell, 83, 517-519.
133. SAKSELA O. and RIFKIN D. B. (1990): Release of basic fibroblast growth factor-heparan sulfate complex from endothelial cells by plasminogen activator-mediated proteolitic activity. J. Cell Biol., 110, 767-775.
134. SANDVIG K. and OLSNES S. (1980): Diphtheria toxin entry into cells is facilitated by low pH. J. Cell Biol., 87, 828-832.
135. SANDVIG K. and OLSNES S. (1988): Diphtheria toxin-induced channels in Vero cells selective for monovalent cations. J. Biol. Chem., 263, 12352-12359.
136. SANDVIG K., SUDAN A. and OLSNES S. (1984): Evidence that diphtheria toxin and modeccin enter the cytosol from different vescular compartments. J. Cell Biol., 98, 963-970.
137. SANDVIG K., TØNNESSEN T. I., SAND O. and OLSNES S. (1986): Requirement of a transmembrane pH gradient for the entry of diphtheria toxin into cells at low pH. J. Biol. Chem., 261, 11639-11644.
138. SANO H., FOROUGH R. M., MAIER A. J., CASE J. P., JACKSON A., ENGLEKA K., MACIAG T. and WILDER L. R. J. (1990): Detection of high levels of heparin binding growth factor (acidic fibroblast growth factor) in inflammatory arthritic joins. J. Cell Biol., 10, 1417-1426.
139. SCHLESSINGER J. and ULLRICH A. (1992): Growth factor signaling by receptor tyrosine kinase. Neuron, 9, 383-391.
140. SCHMIT M. P., TWIDDY E. M. and HOLMES R. K. (1922): Purification and characterization of the diphtheria toxin repressor. Proc. Natl. Acad. Sci. USA, 89, 1647-1651.
141. SHARMA R. C., INOUE S., ROITELMAN J., SCHIMKE R. T. and SIMONI R. D. (1992): Peptide transport by the multidrug resistance pump. J. Biol. Chem., 267, 5731-5734.
142. SHI E., KAN M., XU J., WANG F., HOU J. and MCKEEHAN W. L. (1993): Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization od combinatoral splice variants. Mol. Cell Biol., 13, 3907-3918.
143. SMALHEISER R. N. (1996): Proteins in unexpected location. Mol. Biol. Cell, 7, 1003-1014.
144. SMITH W. P. (1980): Cotranslational secretion of diphtheria toxin and alkaline phosphatase in vitro: involvement of membrane protein(s). J. Bacteriol., 141, 1142-1147.
145. SOLARI R., SMITHERS N., KENNARD N., RAY K. and GRENFELL S. (1994): Receptor mediated endocytosis and intracellular fate of interlaeukin 1. Biochem. Pharmacol., 47, 93-101.
146. SPIVAK-KROIZMAN T., LEMMON M. A., DIKIC I., LADBURY J. E., PINCHASI D., HUOANG J., JAUE M., CRUMLY G., SCHLESSINGER J. and LAX I. (1994): Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell, 79, 1015-1024.
147. STACHOWIAK M. K., MATHER P. A., JOY A., MORDECHAI E. and STACHOWIAK E. K. (1996): Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. Mol. Biol. Cell, 7, 1299-1317.
148. STENMARK H., MOSKAUGH J. Ø., MADSHUS I. H., SANDVIG K. and OLSNES S. (1991): Peptides fused to the amminoterminal end of diphtheria toxin are translocated to the cytosol. J. Cell Biol., 113, 1025-1032.
149. TAMM I., KIKUCHI T. and ZYCHLINSKI A. (1991): Acidic and basic fibroblast growth factors are survival factors with distinctive activity in quiescent BALB/c 3T3 murine fibroblast Proc. Natl. Acad. Sci. USA, 88, 3372-3376.
150. TANAKA A., MIYAMOTO K., MINAMINO N., TAKEDA M., SATO B., MATSUO H. and MATSUMOTO K. (1992): Cloning and characterization of an androgen induced growth factor essential for androgen-dependent growth of mouse mammary tumor cells. Proc. Natl. Acad. Sci. USA, 89, 8928-8932.
151. TRUSH G. R., LARK L. R., CLINCHY B. C. and VITETTA E. S. (1996): Immunotoxins - an update. Annu. Rev. Immunol., 14, 49-71.
152. UCHIDA T., GILL D. M. and PAPPENHEIMER A. M. JR. (1971): Mutation in the structural gene for diphtheria toxin carried by temperate phage. Nat. New Biol., 233, 9-11.
153. UENO H., GUNN M., DELL K., TSENG A. and WILLIAMS L. T. (1992): A truncated form of fibroblast growth factor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J. Biol. Chem., 267, 1470-1476.
154. ULLRICH A. and SCHLESSINGER J. (1990): Signal transduction by receptors with tyrosine kinase activity. Cell, 61, 203-212.
155. UMATA T., MORIYAMA Y., FUTAI M. and MEKADA E. (1990): Rhe cytotoxic action of diphtheria toxin and its degradation in intact Vero cells are inhibited by bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase. J. Biol. Chem., 265, 21940-21945.
156. VAINIKA S., JOUKOW V., KLINT P. and ALITALO K. (1995): Association of a 85 kDa serine kinase with activated fibroblast growth factor receptor-4. J. Biol. Chem., 271, 1270-1273.
157. VAN DEURS B., HANSEN S. H., OLSNES S. and SANDVIG K. (1993): Protein uptake and cytoplasmic access in animal cells. In AUDUS K. L. and RAUB T. J. (eds.): Biological barriers to protein delivery. Plenum Press, New York, 71-194.
158. VAN NESS B. G., HOWARD J. B. and BODLEY J. W. (1980): ADP-rybosylation of elongation factor 2 by diphtheria toxin. NMR spectra and proposed structures of ribosyl-diphthiamide and its hydrolysis product. J. Biol. Chem., 255, 10710-10716.
159. WALTER P. (1994): Protein translocation across the endoplasmic reticulum. Curr. Opin. Cell Biol., 6, 510-516.
160. WESTENDORP M. O., FRANK R., OCHSENBAUER C., STRICKER K., DHEIN J., WALCZAK H., DEBATIN K. M. and KRAMER P. H. (1995): Sensitization of T cells to CD95-mediated appoptosis by HIV-1 Tat and gp120. Nature, 375, 497-500.
161. WIEDLOCHA A., FÅLNES P. Ø., MADSHUS I. H., SANDVIG K. and OLSNES S. (1994): Dual mode of signal transduction by externally added acidic fibroblast growth factor. Cell, 76, 1039-1051.
162. WIEDLOCHA A., FÅLNES P. Ø., RAPAK A., KLINGENBERG O., MUNOZ R. and OLSNES S. (1995): Translocation to cytosol of exogenous, CaaX-tagged acidic fibroblast growth factor. J. Biol. Chem., 270, 30680-39685.
163. WIEDLOCHA A., FÅLNES P. Ø., RAPAK A., MUNOZ R., KLINGENBERG O. and OLSNES S. (1996): Stimulation of proliferation of a human osteosarcoma cell line by exogenous acidic fibroblast growth factor required both activation of receptor kinase and growth factor internalization. Mol. Cell. Biol., 16, 270-280.
164. WIEDLOCHA A., MADSHUS I. H., MACH H., MIDDAUGH C. R. and OLSNES S. (1992): Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector. EMBO J., 11, 4835-4842.
165. WIEDLOCHA A., SALWA J., PAPROCKA M., STEUDEN I. and RADZIKOWSKI C. (1989): Specific kiling of mouse leukemic cells with ricin A-chain immunotoxin. Arch. Immunol. Ther. Exp., 37, 101-113.
166. WIEDLOCHA A., SANDVIG K., WALZEL H., RADZIKOWSKI C., and OLSNES S. (1991): Internalization and action of an immunotoxin containing mistletoe lectin A-chain. Cancer Res., 51, 916-920.
167. WIETZ J. H. J. E., TORTORELLA D., BOGYO M., YU J., MOTHES W., JONES R. T., RAPOPORT A. T. and PLOEGH L. H. (1996): Sec61-mediated transfer of a membrane protein from the endoplasmatic reticulum to the proteasome for destruction. Nature, 384, 432-438.
168. XU J., NAKAHARA M., CRABB J. W., SHI E., MATUO Y., FRASER M., KAN M., HOU J. and MCKEEHAN W. L. (1992): Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms. J. Biol. Chem., 267, 17792-17803.
169. YAMAIZUMI M., MEKADA E., UCHIDA T. and OKADA Y. (1978): One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell, 15, 245-250.
170. YAN G., FUKABORI Y., MCBRIDE G., NIKOLARPOLOUS S. and MCKEEHAN W. L. (1993): Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol. Cell. Biol., 13, 4513-4522.
171. YAYON A., KLAGSBRUN M., ESKO J. D., LEDER P. and ORNIZ D. M. (1991): Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64, 841-848.
172. ZHAN X., HU X., FRIEDMAN S. and MACIAG T. (1992): Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH3T3 cells. Biochem. Biophys. Res. Commun., 188, 982-991.
173. ZHAN X., HU X., FRIESEL R. and MACIAG T. (1993): Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. J. Biol. Chem., 268, 9611-9620.
174. ZHAN X., HU X., HAMPTON B., BURGESS W. H., FRIESEL R. and MACIAG T. (1993): Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G1 phase of BALB/c 3T3 cell cycle. J.
175. ZHAN X., PLOURDE C., HU X. and MACIAG T. (1994): Association of fibroblast growth factor receptor-1 with c-SCR correlates with association between c-SRC and cortactin. J. Biol. Chem., 269, 20221-20224.
176. ZHU X., KOMIYA H., CHIRINO A., FAHAM S., FOX G. M., ARAKAWA T., HSU B. T. and REES D. C. (1991): Three-dimentional structure of acidic and basic fibroblast growth factors. Science, 251, 90-93.
177. ZIMMER Y., GIVOL D. and YAYON A. (1993): Multiple structural elements determine ligand binding of fibroblast growth factor receptors. J. Biol. Chem., 268, 7899-7903.
178. ZUNIGA MEIJER BORJA A. Z., MEJERS C. and ZELLER R. (1992): Expression of alternatively spliced bFGF first coding exons and antisense RNAs during chicken embryogenesis. Dev. Biol., 157, 110-118.